The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma

被引：53

作者：

Bhende, P. M. ^{[1
,2
]}

Park, S. I. ^{[1
,2
]}

Lim, M. S. ^{[3
]}

Dittmer, D. P. ^{[1
,2
]}

Damania, B. ^{[1
,2
]}

机构：

[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

[2] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA

[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA

来源：

LEUKEMIA | 2010年 / 24卷 / 10期

关键词：

IN-VIVO; RAPAMYCIN; CELLS; PATHWAYS; TARGET;

D O I：

10.1038/leu.2010.154

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：1781 / 1784

页数：5

共 12 条

[1]

ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo [J].

Ackler, Scott ;

Xiao, Yu ;

Mitten, Michael J. ;

Foster, Kelly ;

Oleksijew, Anatol ;

Refici, Marion ;

Schlessinger, Sally ;

Wang, Baole ;

Chemburkar, Sanjay R. ;

Bauch, Joy ;

Tse, Christin ;

Frost, David J. ;

Fesik, Stephen W. ;

Rosenberg, Saul H. ;

Elmore, Steven W. ;

Shoemaker, Alex R. .

MOLECULAR CANCER THERAPEUTICS, 2008, 7 (10) :3265-3274

[2]

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations [J].

Dubrovska, Anna ;

Kim, Sungeun ;

Salamone, Richard J. ;

Walker, John R. ;

Maira, Sauveur-Michel ;

Garcia-Echeverria, Carlos ;

Schultz, Peter G. ;

Reddy, Venkateshwar A. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (01) :268-273

[3]

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogenactivated protein kinase as a target for therapy [J].

Elenitoba-Johnson, KSJ ;

Jenson, SD ;

Abbott, RT ;

Palais, RA ;

Bohling, SD ;

Lin, ZS ;

Tripp, S ;

Shami, PJ ;

Wang, LY ;

Coupland, RW ;

Buckstein, R ;

Perez-Ordonez, B ;

Perkins, SL ;

Dube, ID ;

Lim, MS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) :7259-7264

[4]

Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011

[5]

Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma [J].

Gulmann, C ;

Espina, V ;

Petricoin, E ;

Longo, DL ;

Santi, M ;

Knutsen, T ;

Raffeld, M ;

Jaffe, ES ;

Liotta, LA ;

Feldman, AL .

CLINICAL CANCER RESEARCH, 2005, 11 (16) :5847-5855

[6]

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive [J].

Jacinto, E ;

Loewith, R ;

Schmidt, A ;

Lin, S ;

Rüegg, MA ;

Hall, A ;

Hall, MN .

NATURE CELL BIOLOGY, 2004, 6 (11) :1122-U30

[7]

Syk-dependent mTOR activation in follicular lymphoma cells [J].

Leseux, Ludivine ;

Hamdi, Safouane M. ;

al Saati, Talal ;

Capilla, Florence ;

Recher, Christian ;

Laurent, Guy ;

Bezombes, Christine .

BLOOD, 2006, 108 (13) :4156-4162

[8]

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity [J].

Maira, Sauveur-Michel ;

Stauffer, Frederic ;

Brueggen, Josef ;

Furet, Pascal ;

Schnell, Christian ;

Fritsch, Christine ;

Brachmann, Saskia ;

Chene, Patrick ;

De Pover, Alain ;

Schoemaker, Kevin ;

Fabbro, Doriano ;

Gabriel, Daniela ;

Simonen, Marjo ;

Murphy, Leon ;

Finan, Peter ;

Sellers, William ;

Garcia-Echeverria, Carlos .

MOLECULAR CANCER THERAPEUTICS, 2008, 7 (07) :1851-1863

[9]

AKT/PKB signaling: Navigating downstream [J].

Manning, Brendan D. ;

Cantley, Lewis C. .

CELL, 2007, 129 (07) :1261-1274

[10]

Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib [J].

Shringarpure, Reshma ;

Catley, Laurence ;

Bhole, Deepak ;

Burger, Renate ;

Podar, Klaus ;

Tai, Yu-Tzu ;

Kessler, Benedikt ;

Galardy, Paul ;

Ploegh, Hidde ;

Tassone, Pierfrancesco ;

Hideshima, Teru ;

Mitsiades, Constantine ;

Munshi, Nikhil C. ;

Chauhan, Dharminder ;

Anderson, Kenneth C. .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) :145-156

← 1 2 →